Cybin (HELP) Gains from Investment Securities (2021 - 2026)
Cybin (HELP) posted quarterly Gains from Investment Securities of $11.0 million for Q1 2026, up 3138.67% on a QoQ basis from -$362000.0 in Q4 2025.
Cybin (HELP) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Gains from Investment Securities for 5 consecutive years, with $11.0 million the latest figure, recorded in Q1 2026.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (changed N/A YoY) and the FY2026 annual result came in at $5.5 million, changed N/A from the prior year.
- Gains from Investment Securities advanced to $11.0 million in Q1 2026 per HELP's latest filing, from -$362000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for HELP reached as high as $11.0 million in Q1 2026 and fell as low as -$5.1 million in Q3 2025.
- A 4-year average of $884835.3 and a median of -$103544.8 in 2022 frame the typical range for Gains from Investment Securities.
- The largest YoY upside for Gains from Investment Securities was 96.82% in 2022 against a maximum downside of 96.82% in 2022.
- Year by year, Gains from Investment Securities stood at $16101.7 in 2022, then tumbled by 1424.94% to -$213337.2 in 2023, then plunged by 69.68% to -$362000.0 in 2025, then jumped by 3138.67% to $11.0 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $11.0 million, -$362000.0, and -$5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.00 Mn |
| Mar 31, 2026 | 11.00 Mn |
| Dec 31, 2025 | -362,000.00 |
| Dec 31, 2025 | -362,000.00 |
| Sep 30, 2025 | -5.14 Mn |
| Sep 30, 2025 | -5.14 Mn |
| Feb 28, 2023 | -213,337.20 |
| Feb 28, 2023 | -213,337.20 |
| Sep 30, 2022 | 16,101.67 |
| Sep 30, 2022 | 16,101.67 |
| May 31, 2022 | 6,247.57 |
| May 31, 2022 | 6,247.57 |
| Dec 31, 2021 | 551,368.58 |
| Dec 31, 2021 | 551,368.58 |
| Sep 30, 2021 | 506,038.73 |
| Sep 30, 2021 | 506,038.73 |
| Jun 30, 2021 | 497,878.62 |
| Jun 30, 2021 | 497,878.62 |